Apotex recalls its drug in the US

The company is recalling about 92K bottles of its hypertension drug in the US


It has been classified as a class-II recall

Apotex is recalling 91,962 bottles of Losartan potassium tablets in the US, due to "failed content uniformity specifications."

The drugs were manufactured by the company's Indian arm Apotex Research Pvt Ltd.

It has been classified as a class-II recall which FDA defined as "a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote."


Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email